Possible roles of IL-12-family cytokines in rheumatoid arthritis
- 23 October 2012
- journal article
- review article
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 9 (4) , 252-256
Abstract
The IL-12 family cytokines contribute to immune-mediated inflammation and have an important role in determining T-cell fate. Evidence from preclinical and clinical studies suggests a role of these cytokines in the pathogenesis of rheumatoid arthritis (RA). The authors discuss these data and their potential clinical implications for patients with RA. The IL-12 family members, IL-12, IL-23, IL-27 and IL-35, are heterodimeric cytokines that share subunits and have important roles in autoimmunity. As well as their structural relationship the IL-12 family cytokines share some biological characteristics but have functional differences. These cytokines contribute to immune-mediated inflammation and our improved knowledge of their actions has led to alteration of the TH1–TH2 paradigm. In rheumatoid arthritis (RA), leukocyte migration, bone erosions and angiogenesis are modulated by an IL-23–IL-17 cascade, which can be negated in part by IL-12, IL-27 and IL-35 function. However, the IL-12 family members are a relatively new area of research and data have been generated mostly at the preclinical stage. Further studies in patients with RA are, therefore, required to determine whether these cytokines are valid targets for RA therapy.Keywords
This publication has 54 references indexed in Scilit:
- The composition and signaling of the IL-35 receptor are unconventionalNature Immunology, 2012
- New directions in the basic and translational biology of interleukin-27Trends in Immunology, 2012
- Local expression of interleukin‐27 ameliorates collagen‐induced arthritisArthritis & Rheumatism, 2011
- IL-35-mediated induction of a potent regulatory T cell populationNature Immunology, 2010
- Interleukin‐27 inhibits human osteoclastogenesis by abrogating RANKL‐mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signalingArthritis & Rheumatism, 2010
- Interleukin‐35: odd one out or part of the family?Immunological Reviews, 2008
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)The Lancet, 2008
- Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destructionJournal of Experimental Medicine, 2006
- The IL-23/IL-17 axis in inflammationJournal of Clinical Investigation, 2006
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999